December 18, 2014 11:52 PM ET

Biotechnology

Company Overview of Helmholtz Zentrum München, GmbH

Executive Profile

Axel Polack Ph.D.

AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 8 different industries.

See Board Relationships
57--

Background

Dr. Axel Polack, Ph.D. serves as a Director of Noxxon Pharma AG. He is a Venture Partner at TVM Capital GmbH focusing on investments in life sciences. He was a General Partner since March 2006 at TVM Capital GmbH. Dr. Polack joined TVM Capital GmbH in December 2000, and was a part of the Life Science team. As an Investment Manager he made investments for it in project-focused companies as well as traditional venture capital investments. Dr. Axel Polack has worked for ...

Corporate Headquarters

Ingolstädter Landstraße 1
Neuherberg, Bavaria 85764

Germany

Phone: 49 89 31870
Fax: 49 89 3187 3322

Board Members Memberships

Director
2007-2014
Former Director and Chairman of Nominating & Corporate Governance Committee
2010-N/A
Former Director

Education

Doctorate
University of Freiburg

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Helmholtz Zentrum München, GmbH, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.